152 related articles for article (PubMed ID: 37941514)
21. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
[TBL] [Abstract][Full Text] [Related]
22. Deficits in basal and evoked striatal dopamine release following alpha-synuclein preformed fibril injection: An in vivo microdialysis study.
Centner A; Del Priore I; Chambers N; Cohen SR; Terry ML; Coyle M; Glinski J; Stoll AC; Patterson JR; Kemp CJ; Miller KM; Kubik M; Kuhn N; Luk KC; Sortwell CE; Bishop C
Eur J Neurosci; 2024 Apr; 59(7):1585-1603. PubMed ID: 38356120
[TBL] [Abstract][Full Text] [Related]
23. Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra.
Burke MV; Nocjar C; Sonneborn AJ; McCreary AC; Pehek EA
J Neurochem; 2014 Nov; 131(4):432-43. PubMed ID: 25073477
[TBL] [Abstract][Full Text] [Related]
24. Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation.
Liu G; Yu J; Ding J; Xie C; Sun L; Rudenko I; Zheng W; Sastry N; Luo J; Rudow G; Troncoso JC; Cai H
J Clin Invest; 2014 Jul; 124(7):3032-46. PubMed ID: 24865427
[TBL] [Abstract][Full Text] [Related]
25. Novel Ca2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum.
Chen BT; Rice ME
J Neurosci; 2001 Oct; 21(19):7841-7. PubMed ID: 11567075
[TBL] [Abstract][Full Text] [Related]
26. Voltage-Gated Ca
Ortner NJ
Front Synaptic Neurosci; 2021; 13():636103. PubMed ID: 33716705
[TBL] [Abstract][Full Text] [Related]
27. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
28. Extracellular S100B inhibits A-type voltage-gated potassium currents and increases L-type voltage-gated calcium channel activity in dopaminergic neurons.
Bancroft EA; De La Mora M; Pandey G; Zarate SM; Srinivasan R
Glia; 2022 Dec; 70(12):2330-2347. PubMed ID: 35916350
[TBL] [Abstract][Full Text] [Related]
29. Striatal dopamine transmission is subtly modified in human A53Tα-synuclein overexpressing mice.
Platt NJ; Gispert S; Auburger G; Cragg SJ
PLoS One; 2012; 7(5):e36397. PubMed ID: 22570709
[TBL] [Abstract][Full Text] [Related]
30. Up and Down γ-Synuclein Transcription in Dopamine Neurons Translates into Changes in Dopamine Neurotransmission and Behavioral Performance in Mice.
Pavia-Collado R; Rodríguez-Aller R; Alarcón-Arís D; Miquel-Rio L; Ruiz-Bronchal E; Paz V; Campa L; Galofré M; Sgambato V; Bortolozzi A
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163729
[TBL] [Abstract][Full Text] [Related]
31. Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse.
Taylor TN; Potgieter D; Anwar S; Senior SL; Janezic S; Threlfell S; Ryan B; Parkkinen L; Deltheil T; Cioroch M; Livieratos A; Oliver PL; Jennings KA; Davies KE; Ansorge O; Bannerman DM; Cragg SJ; Wade-Martins R
Neurobiol Dis; 2014 Feb; 62():193-207. PubMed ID: 24121116
[TBL] [Abstract][Full Text] [Related]
32. Calcium, ageing, and neuronal vulnerability in Parkinson's disease.
Surmeier DJ
Lancet Neurol; 2007 Oct; 6(10):933-8. PubMed ID: 17884683
[TBL] [Abstract][Full Text] [Related]
33. Recruitment of calbindin into nigral dopamine neurons protects against MPTP-Induced parkinsonism.
Inoue KI; Miyachi S; Nishi K; Okado H; Nagai Y; Minamimoto T; Nambu A; Takada M
Mov Disord; 2019 Feb; 34(2):200-209. PubMed ID: 30161282
[TBL] [Abstract][Full Text] [Related]
34. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
[TBL] [Abstract][Full Text] [Related]
35. LRRK2 BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function.
Sloan M; Alegre-Abarrategui J; Potgieter D; Kaufmann AK; Exley R; Deltheil T; Threlfell S; Connor-Robson N; Brimblecombe K; Wallings R; Cioroch M; Bannerman DM; Bolam JP; Magill PJ; Cragg SJ; Dodson PD; Wade-Martins R
Hum Mol Genet; 2016 Mar; 25(5):951-63. PubMed ID: 26744332
[TBL] [Abstract][Full Text] [Related]
36. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
Biondetti E; Santin MD; Valabrègue R; Mangone G; Gaurav R; Pyatigorskaya N; Hutchison M; Yahia-Cherif L; Villain N; Habert MO; Arnulf I; Leu-Semenescu S; Dodet P; Vila M; Corvol JC; Vidailhet M; Lehéricy S
Brain; 2021 Nov; 144(10):3114-3125. PubMed ID: 33978742
[TBL] [Abstract][Full Text] [Related]
37. The L-type calcium channel blocker, isradipine, attenuates cue-induced cocaine-seeking by enhancing dopaminergic activity in the ventral tegmental area to nucleus accumbens pathway.
Addy NA; Nunes EJ; Hughley SM; Small KM; Baracz SJ; Haight JL; Rajadhyaksha AM
Neuropsychopharmacology; 2018 Nov; 43(12):2361-2372. PubMed ID: 29773910
[TBL] [Abstract][Full Text] [Related]
38. Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release.
Patel JC; Witkovsky P; Avshalumov MV; Rice ME
J Neurosci; 2009 May; 29(20):6568-79. PubMed ID: 19458227
[TBL] [Abstract][Full Text] [Related]
39. Inflammation alters AMPA-stimulated calcium responses in dorsal striatal D2 but not D1 spiny projection neurons.
Winland CD; Welsh N; Sepulveda-Rodriguez A; Vicini S; Maguire-Zeiss KA
Eur J Neurosci; 2017 Nov; 46(9):2519-2533. PubMed ID: 28921719
[TBL] [Abstract][Full Text] [Related]
40. Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.
Richter F; Gao F; Medvedeva V; Lee P; Bove N; Fleming SM; Michaud M; Lemesre V; Patassini S; De La Rosa K; Mulligan CK; Sioshansi PC; Zhu C; Coppola G; Bordet T; Pruss RM; Chesselet MF
Neurobiol Dis; 2014 Sep; 69():263-75. PubMed ID: 24844147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
